Pre-IVF testing: a patient guide
Pre-IVF testing: what usually happens
Starting IVF can make the calendar feel crowded before treatment has even begun. A clear evaluation helps, but it should not become a long list of tests collected simply because they are available.
The useful question is: which result could change the treatment plan, its timing or its safety? The answer depends on your age, menstrual history, previous pregnancies or IVF, medical conditions, family history and the sperm source being used.
Quick answer
Before IVF, the team usually reviews both partners’ history, ovarian function when relevant, the uterus and tubes when that information could change the plan, and semen analysis when sperm will be used. The exact list is individual. A normal result can answer one question, but no single test predicts the outcome of a cycle.
The ASRM fertility evaluation guidance recommends a systematic evaluation that is tailored to the clinical history rather than a fixed test package.
At a glance: what each review is for
| Test or review | What it helps assess | Is it automatic? |
|---|---|---|
| Medical history and cycle review | Previous treatment, menstrual pattern, health conditions and family history | Yes, it is part of the consultation |
| AMH, antral follicle count and selected hormones | Ovarian reserve and possible response to stimulation | Chosen according to the clinical context |
| Ultrasound, with further uterus or tube tests when relevant | The ovaries, uterus and—when needed—the fallopian tubes | Ultrasound is common; additional tests are selective |
| Semen analysis | Sperm concentration, movement, shape and volume | Usually the first male-partner test when sperm will be used |
| Genetic testing or counselling | A known or suspected inherited risk | Discussed when personal, family or test history gives a reason |
These are guideposts, not a universal checklist. The purpose is to choose tests that answer a real question or could change the plan.
What is reviewed before IVF?
The first appointment is often more useful when it starts with the story: cycle pattern, previous pregnancies, prior treatments, operations, medications, allergies and family history. Bring previous fertility results if you have them. Repeating a recent, reliable test is not always necessary.
Ovarian reserve and ovulation
Depending on the situation, the clinician may discuss:
- AMH: a marker that helps estimate ovarian reserve and anticipate response to stimulation. It does not measure egg quality and cannot predict pregnancy on its own.
- Antral follicle count: a transvaginal ultrasound count of small follicles. It is interpreted alongside age, history and other findings.
- FSH and estradiol: when useful, these are usually measured together in the early follicular phase, often on cycle days 2–4.
- TSH or prolactin: these are considered when the menstrual history, symptoms or medical background gives a reason. Prolactin is not a routine test for every person with regular cycles.
The ASRM guidance describes ovarian-reserve testing as an aid for planning stimulation, not as a stand-alone fertility test.
The uterus and fallopian tubes
A transvaginal ultrasound is commonly used to look at the ovaries and uterus. Further assessment may include HSG, HyCoSy or saline sonography when the result could change the diagnosis or treatment plan.
Tubal testing is not automatically needed for every person proceeding to IVF. If both tubes are clearly not central to the plan, the clinician may decide that another test would add little. Hysteroscopy is useful when symptoms, imaging or history suggest a problem inside the uterine cavity; it is not a routine checkbox for everyone. A mock transfer may be discussed after a difficult transfer or when the anatomy suggests that rehearsal could help.
Infection, vaccination and general health
The clinic and laboratory may require particular infection tests under local rules and clinical protocols. Your medical team may also review vaccination status, medications, chronic conditions and preconception health. If rubella or varicella vaccination is needed, live vaccines are generally given before pregnancy; ACOG notes that vaccination should be completed at least 28 days before pregnancy is attempted. See the ACOG prepregnancy counseling guidance.
An active infection or an untreated medical problem may need attention before treatment. That does not automatically mean IVF is impossible. It means the order and timing of care should be discussed clearly.
General, carrier and genetic tests
Blood count, blood group, glucose, kidney or liver tests, vitamin levels and genetic tests are selected according to the person, the planned medication and the relevant medical or family history. They are not a universal pre-IVF panel.
Carrier screening may be discussed before pregnancy. Karyotype or other genetic testing may be appropriate after recurrent pregnancy loss, a relevant family history, diminished ovarian function at a young age, or severe male-factor findings. Genetic counseling helps explain what a result would and would not change.
What is usually checked for the male partner?
When sperm will be used, both partners can be evaluated in parallel. The first step is usually a reproductive history and at least one semen analysis. The result is read as a pattern: concentration, motility, morphology, volume and other laboratory measures are considered together.
If the result is abnormal, the test may be repeated and a male-reproductive specialist may be involved. Hormone tests are more useful when there is severe sperm impairment, azoospermia, a relevant examination finding or a symptom that suggests an endocrine cause. Sperm culture is considered when infection is suspected, not as an automatic test for every man.
Karyotype and Y-chromosome microdeletion testing are reserved for selected cases of azoospermia or severe oligozoospermia with findings that suggest impaired sperm production. The AUA/ASRM male infertility guideline gives the clinical context for these tests.
Tests that are not automatic
More testing is not always more helpful. Broad immune panels, repeated endometrial tests and commercial add-on packages should not be treated as routine preparation for every IVF cycle. The ASRM guideline on immunology in IVF notes that routine immunological testing in the general ART population cannot be recommended on the available evidence.
The same principle applies to PGT. PGT-M or PGT-SR may be relevant when a known genetic risk is present. PGT-A is a separate question, and the ASRM 2024 committee opinion notes that its routine use for every IVF patient has not been established. A test can provide useful information without guaranteeing a healthy embryo or a pregnancy.
When might another test be considered?
| Situation | Possible next discussion | Why it may matter |
|---|---|---|
| Irregular cycles or symptoms suggesting a hormonal issue | Targeted hormone tests or an ultrasound review | It may clarify ovulation or another treatable issue |
| Previous pelvic infection, surgery or suspected tubal disease | A focused assessment of the tubes | The result may affect the diagnosis or timing |
| An abnormal semen analysis | A repeat analysis and, when appropriate, male-infertility review | Results can vary and may point to the next step |
| A known family genetic condition or repeated pregnancy loss | Genetic counselling and targeted testing | It can clarify whether a specific genetic test is relevant |
| A previous difficult embryo transfer or concern about the uterine cavity | Hysteroscopy or a mock-transfer discussion | The team may want to understand the anatomy before transfer |
Not every situation calls for every test. Your clinician should explain what a result would change before ordering it.
When should a fertility evaluation begin?
The familiar 12-month and 6-month time points are thresholds for starting an infertility evaluation when there is no known cause: 12 months under age 35 and 6 months from age 35. They are not instructions to wait if there are irregular cycles, suspected tubal disease, known male-factor infertility, a history that may reduce ovarian reserve or age over 40. In those situations, earlier evaluation is reasonable. This is the approach described in the ASRM fertility evaluation guidance.
What happens after the results?
The next step is a conversation, not an automatic treatment order. The clinician reviews what the findings mean together, which questions remain open and whether any result changes the timing or method of treatment.
Depending on the situation, the discussion may include ovarian stimulation, egg retrieval, IVF or ICSI, embryo transfer, freezing or a genetic consultation. Read more about stimulation of the ovaries, egg retrieval, fertilisation by IVF or ICSI and embryo transfer.
Dr. Aksoy’s Approach
I do not use one pre-IVF checklist for everyone. The useful test is the one that answers a real question or changes the plan; the longest list is not automatically the safest one. A reassuring result is helpful, but it should never be presented as a promise about the outcome of a cycle.
Frequently asked questions
Which tests are usually considered before IVF?
The starting point is usually a review of both partners’ history, ovarian assessment when relevant, an assessment of the uterus or tubes when it could change the plan, and at least one semen analysis when sperm will be used. Other tests are added only when the history or first results give a reason.
Does everyone need a hysterosalpingogram before IVF?
No. A hysterosalpingogram or HyCoSy may be useful when tubal information could change the diagnosis or treatment plan, but it is not an automatic requirement for every IVF patient.
What does AMH tell me before IVF?
AMH is one marker of ovarian reserve and can help the team anticipate ovarian response to stimulation. It does not measure egg quality and, on its own, cannot predict whether you will become pregnant.
When should we start a fertility evaluation?
If there is no known problem, evaluation is generally considered after 12 months of trying before age 35 and after 6 months from age 35. At age 40 or above, or when there are irregular cycles, suspected tubal disease or male-factor concerns, it is sensible to seek an evaluation sooner.
What should male partner testing include?
The first step is usually a reproductive history and semen analysis. Hormone tests, genetic tests or a specialist examination are considered when the semen result or history suggests a specific cause.
Related reading
Medical note
This page is for general information. The appropriate tests depend on your medical history, examination, previous results and treatment plan. A fertility specialist can explain which findings matter for your situation.
Sources
- American Society for Reproductive Medicine: Fertility evaluation of infertile women
- American Urological Association and ASRM: Diagnosis and treatment of infertility in men
- ACOG: Prepregnancy counseling
- ASRM: The role of immunotherapy in IVF
- ASRM: The use of preimplantation genetic testing for aneuploidy
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
